| 1 | [SID49722562] | Active | Potency | 15.8489 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 2 | [SID49722562] | Active | Potency | 15.8489 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 3 | [SID49722562] | Active | Potency | 24.5297 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: THP1 Hit Validation [AID492949, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 24.5297 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: THP1 Hit Validation | | AID | 492949 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 4 | [SID49722562] | Active | Potency | 24.5297 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: THP1 Hit Validation [AID492949, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 24.5297 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: THP1 Hit Validation | | AID | 492949 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 5 | [SID49722562] | Active | Potency | 27.5227 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation [AID489012, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 27.5227 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation | | AID | 489012 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 6 | [SID49722562] | Active | Potency | 27.5227 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation [AID489012, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 27.5227 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation | | AID | 489012 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 7 | [SID49722562] | Active | Potency | 30.881 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation [AID492948, Type: confirmatory] | vasopressin V1b receptor [Homo sapiens] [gi:4502333] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 30.881 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation | | AID | 492948 | | BioAssay type | confirmatory | | Target | vasopressin V1b receptor [Homo sapiens] [gi:4502333] | | PubMed | | | Data Table |  |
|
| 8 | [SID49722562] | Active | Potency | 30.881 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation [AID492948, Type: confirmatory] | vasopressin V1b receptor [Homo sapiens] [gi:4502333] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 30.881 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation | | AID | 492948 | | BioAssay type | confirmatory | | Target | vasopressin V1b receptor [Homo sapiens] [gi:4502333] | | PubMed | | | Data Table |  |
|
| 9 | [SID49722562] | Active | Potency | 30.881 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation [AID492948, Type: confirmatory] | vasopressin V1b receptor [Homo sapiens] [gi:4502333] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 30.881 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation | | AID | 492948 | | BioAssay type | confirmatory | | Target | vasopressin V1b receptor [Homo sapiens] [gi:4502333] | | PubMed | | | Data Table |  |
|
| 10 | [SID49722562] | Active | Potency | 34.6491 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation [AID489043, Type: confirmatory] | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 34.6491 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation | | AID | 489043 | | BioAssay type | confirmatory | | Target | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] | | PubMed | | | Data Table |  |
|
| 11 | [SID49722562] | Active | Potency | 34.6491 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation [AID489043, Type: confirmatory] | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | Potency | 34.6491 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation | | AID | 489043 | | BioAssay type | confirmatory | | Target | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] | | PubMed | | | Data Table |  |
|
| 12 | [SID49722562] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 13 | [SID49722562] | Active | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Active | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 14 | [SID49722562] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 15 | [SID49722562] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 16 | [SID49722562] | Inactive | Potency | 13.1154 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | 13.1154 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID49722562] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624377, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624377 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 18 | [SID49722562] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 19 | [SID49722562] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 20 | [SID49722562] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 21 | [SID49722562] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 22 | [SID49722562] | Inactive | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 23 | [SID49722562] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 24 | [SID49722562] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 25 | [SID49722562] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 26 | [SID49722562] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 27 | [SID49722562] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 28 | [SID49722562] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 29 | [SID49722562] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 30 | [SID49722562] | Inactive | | | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase [AID2805, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase | | AID | 2805 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 31 | [SID49722562] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase [AID2806, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase | | AID | 2806 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 32 | [SID49722562] | Inactive | Potency | | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 33 | [SID49722562] | Inactive | Potency | | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 34 | [SID49722562] | Inactive | | | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) [AID493160, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 493160 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 35 | [SID49722562] | Inactive | | | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) [AID493187, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) | | AID | 493187 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 36 | [SID49722562] | Inactive | IC50 | | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 37 | [SID49722562] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 38 | [SID49722562] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 39 | [SID49722562] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) [AID588511, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) | | AID | 588511 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 40 | [SID49722562] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A) [AID623877, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A) | | AID | 623877 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 41 | [SID49722562] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast [AID2825, Type: screening] | NLRP3 protein [Homo sapiens] [gi:219518789] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast | | AID | 2825 | | BioAssay type | screening | | Target | NLRP3 protein [Homo sapiens] [gi:219518789] | | PubMed | | | Data Table |  |
|
| 42 | [SID49722562] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 43 | [SID49722562] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 44 | [SID49722562] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 45 | [SID49722562] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 46 | [SID49722562] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 47 | [SID49722562] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 48 | [SID49722562] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 49 | [SID49722562] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 50 | [SID49722562] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49722562 | | CID | 20923121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|